Skip to ContentSkip to Navigation
Practical matters How to find us dr. J.S.F. (Jan-Stephan) Sanders


Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant

Antigen and Cell-Based Assays for the Detection of Non-HLA Antibodies

CD163 and CD206 expression define distinct macrophage subsets involved in active ANCA-associated glomerulonephritis

Combining transplant professional's psychosocial donor evaluation and donor self-report measures to optimise the prediction of HRQoL after kidney donation: an observational prospective multicentre study

COVID-19 vaccination in patients with immune thrombocytopenia

COVID-19 vaccination response in kidney transplant recipients with and without mycophenolate mofetil: follow-up of a randomized controlled trial

Early increase in single-kidney glomerular filtration rate after living kidney donation predicts long-term kidney function

Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil-containing Immunosuppressive Regimens

Fasting before living-kidney donation: effect on donor well-being and postoperative recovery: study protocol of a multicenter randomized controlled trial

Read more


Boosters blijken zinvol voor mensen met een getransplanteerde nier

RECOVAC Booster Vaccination Study

De eerste resultaten van onderzoek naar werking coronavaccins